We found that SPP1 was upregulated in breast, bladder, colorectal, head and neck, liver cancer, lung, and esophageal cancers, whereas decreased in kidney cancer and sarcoma (p < 0.05, Fig.1 and Table 1). Here, SPP1 is linked to liver cancer.